This guideline covers support to help women stop smoking during pregnancy and in the first year after childbirth. It includes identifying women who need help to quit, referring them to stop smoking services and providing intensive and ongoing support to help them stop. The guideline also advises how to tailor services for women from disadvantaged groups in which smoking rates are high.
This guideline includes recommendations on:
- identifying pregnant women who smoke and referring them to NHS Stop Smoking services
- contacting and supporting women who have been referred
- use of nicotine replacement therapy (NRT) and other pharmacological support
- meeting the needs of disadvantaged pregnant women who smoke
- partners and others in the household who smoke
- training to deliver interventions
Who is it for?
- Healthcare professionals
- Practitioners working in local authorities, education and the wider public, private, voluntary and community sectors
- Commissioners, managers and providers
- Women who are pregnant or planning a pregnancy, or who have a child aged up to 12 months, and their families and carers
Is this guideline up to date?
We checked the guideline in September 2015 and updated it in March 2018 to remove footnotes from recommendations 4, 5 and 7 that referred to NICE guideline PH10, which has been replaced by NICE's guideline on stop smoking interventions and services (NG92).
Guideline development process
This guideline was previously called quitting smoking in pregnancy and following childbirth.
The recommendations in this guideline represent the view of NICE, arrived at after careful consideration of the evidence available. When exercising their judgement, professionals and practitioners are expected to take this guideline fully into account, alongside the individual needs, preferences and values of their patients or the people using their service. It is not mandatory to apply the recommendations, and the guideline does not override the responsibility to make decisions appropriate to the circumstances of the individual, in consultation with them and their families and carers or guardian.
All problems (adverse events) related to a medicine or medical device used for treatment or in a procedure should be reported to the Medicines and Healthcare products Regulatory Agency using the Yellow Card Scheme.
Local commissioners and providers of healthcare have a responsibility to enable the guideline to be applied when individual professionals and people using services wish to use it. They should do so in the context of local and national priorities for funding and developing services, and in light of their duties to have due regard to the need to eliminate unlawful discrimination, to advance equality of opportunity and to reduce health inequalities. Nothing in this guideline should be interpreted in a way that would be inconsistent with complying with those duties.
Commissioners and providers have a responsibility to promote an environmentally sustainable health and care system and should assess and reduce the environmental impact of implementing NICE recommendations wherever possible.